Prediction: Eli Lilly's Newest GLP-1 Drug Will Be a Game-Changer for the Stock

Drugmaker Eli Lilly (NYSE: LLY) hasn't been exempt from the recent market pullback, but its stock shot higher following the announcement that its newest GLP-1 drug had successfully completed the first of several phase 3 drug trials.The jump in share price propelled the stock into positive territory -- it was up nearly 9% year to date as of this writing, and up about 12% over the past 12 months.Let's look at why this news could be a game-changer for Eli Lilly and its stock.Continue reading

Apr 20, 2025 - 11:25
 0
Prediction: Eli Lilly's Newest GLP-1 Drug Will Be a Game-Changer for the Stock

Drugmaker Eli Lilly (NYSE: LLY) hasn't been exempt from the recent market pullback, but its stock shot higher following the announcement that its newest GLP-1 drug had successfully completed the first of several phase 3 drug trials.

The jump in share price propelled the stock into positive territory -- it was up nearly 9% year to date as of this writing, and up about 12% over the past 12 months.

Let's look at why this news could be a game-changer for Eli Lilly and its stock.

Continue reading